2025-08-26 |
13D/A
|
STTK / Shattuck Labs, Inc.
|
|
5,652,660 |
6,379,095 |
|
|
|
2025-08-15 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,291,092 |
0 |
|
|
|
2025-08-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
4,713,509 |
4,375,931 |
|
|
|
2025-08-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
4,840,463 |
4,150,627 |
|
|
|
2025-08-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
1,765,303 |
|
|
|
2025-08-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
4,942,312 |
5,062,477 |
|
|
|
2025-08-14 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
4,909,264 |
4,641,455 |
|
|
|
2025-08-14 |
13G/A
|
ADCT / ADC Therapeutics SA
|
|
15,669,217 |
15,666,731 |
|
|
|
2025-08-06 |
13D/A
|
STTK / Shattuck Labs, Inc.
|
|
5,624,960 |
5,652,660 |
|
|
|
2025-07-03 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
17,816,634 |
17,941,579 |
|
|
|
2025-05-23 |
13D
|
ATRA / Atara Biotherapeutics, Inc.
|
|
601,243 |
705,207 |
|
|
|
2025-05-15 |
13G/A
|
IMNM / Immunome, Inc.
|
|
4,889,554 |
5,361,187 |
|
|
|
2025-05-15 |
13G/A
|
SLNCF / Silence Therapeutics plc
|
|
7,197,951 |
6,644,841 |
|
|
|
2025-05-15 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
579,541 |
601,243 |
|
|
|
2025-05-15 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
4,604,483 |
4,898,527 |
|
|
|
2025-04-29 |
13D/A
|
ABSI / Absci Corporation
|
|
8,282,016 |
8,335,116 |
|
|
|
2025-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
5,101,911 |
4,840,463 |
|
|
|
2025-02-14 |
13G
|
SLNCF / Silence Therapeutics plc
|
|
|
7,197,951 |
|
|
|
2025-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
8,301,187 |
9,885,124 |
|
|
|
2025-02-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,197,491 |
2,895,478 |
|
|
|
2025-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
3,776,847 |
13,932,449 |
|
|
|
2025-02-14 |
13G/A
|
GRTSQ / Gritstone bio, Inc.
|
|
10,135,388 |
13,163,457 |
|
|
|
2025-02-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
1,050,304 |
1,479,766 |
|
|
|
2025-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
15,376,197 |
14,184,495 |
|
|
|
2024-12-26 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
17,619,095 |
17,816,634 |
|
|
|
2024-12-06 |
13D/A
|
STTK / Shattuck Labs, Inc.
|
|
5,664,892 |
5,624,960 |
|
|
|
2024-11-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
3,760,690 |
4,942,312 |
|
|
|
2024-11-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
5,021,886 |
6,970,307 |
|
|
|
2024-11-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
5,790,230 |
5,101,911 |
|
|
|
2024-11-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,148,748 |
1,942,555 |
|
|
|
2024-11-14 |
13G/A
|
ADCT / ADC Therapeutics SA
|
|
15,328,317 |
15,669,217 |
|
|
|
2024-11-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
21,957,926 |
15,376,197 |
|
|
|
2024-11-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
2,625,506 |
4,713,509 |
|
|
|
2024-11-14 |
13G/A
|
IMNM / Immunome, Inc.
|
|
3,879,415 |
4,889,554 |
|
|
|
2024-11-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
7,706,883 |
8,301,187 |
|
|
|
2024-11-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,733,189 |
810,245 |
|
|
|
2024-11-14 |
13G
|
PLRX / Pliant Therapeutics, Inc.
|
|
2,696,648 |
3,197,491 |
|
|
|
2024-10-04 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
22,131,580 |
0 |
|
|
|
2024-09-13 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
10,301,409 |
579,541 |
|
|
|
2024-07-19 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
22,092,211 |
22,131,580 |
|
|
|
2024-03-25 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
15,049,839 |
17,619,095 |
|
|
|
2024-03-13 |
13D/A
|
LSAQ / LifeSci Acquisition II Corp
|
|
994,529 |
0 |
|
|
|
2024-03-05 |
13D/A
|
ABSI / Absci Corporation
|
|
8,031,094 |
8,282,016 |
|
|
|
2024-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
7,108,097 |
8,359,768 |
|
|
|
2024-02-14 |
13G/A
|
STXS / Stereotaxis, Inc.
|
|
7,097,616 |
3,402,443 |
|
|
|
2024-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
28,599,494 |
21,957,926 |
|
|
|
2024-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
19,896,453 |
16,423,922 |
|
|
|
2024-02-14 |
13G/A
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
332,353 |
211,014 |
|
|
|
2024-02-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
|
1,050,304 |
|
|
|
2024-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
4,899,772 |
5,021,886 |
|
|
|
2024-02-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
4,238,312 |
3,760,690 |
|
|
|
2024-02-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
4,897,575 |
8,083,776 |
|
|
|
2024-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
4,166,975 |
2,625,506 |
|
|
|
2024-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
9,837,493 |
10,301,409 |
|
|
|
2024-02-14 |
13G/A
|
GRTSQ / Gritstone bio, Inc.
|
|
8,483,322 |
10,135,388 |
|
|
|
2024-02-14 |
13G/A
|
TRDA / Entrada Therapeutics, Inc.
|
|
1,854,108 |
1,283,735 |
|
|
|
2024-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
3,679,838 |
3,776,847 |
|
|
|
2024-02-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,896,645 |
1,733,189 |
|
|
|
2024-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
5,740,099 |
4,604,483 |
|
|
|
2024-02-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
2,632,912 |
1,109,476 |
|
|
|
2024-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,684,396 |
2,148,748 |
|
|
|
2024-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
5,460,768 |
1,063,769 |
|
|
|
2024-02-14 |
13G/A
|
LVTX / LAVA Therapeutics N.V.
|
|
2,816,196 |
2,074,372 |
|
|
|
2024-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
6,175,918 |
5,790,230 |
|
|
|
2024-02-14 |
13G/A
|
ADCT / ADC Therapeutics SA
|
|
13,565,249 |
15,328,317 |
|
|
|
2024-02-14 |
13G/A
|
ALXO / ALX Oncology Holdings Inc.
|
|
4,991,545 |
4,909,264 |
|
|
|
2024-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
5,501,389 |
7,706,883 |
|
|
|
2024-02-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,878,599 |
2,696,648 |
|
|
|
2024-02-06 |
13D/A
|
MDVLQ / MedAvail Holdings, Inc.
|
|
|
2,490,137 |
|
|
|
2024-01-31 |
13D/A
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
994,529 |
|
|
|
2023-12-28 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
15,071,096 |
15,049,839 |
|
|
|
2023-12-26 |
13D/A
|
STTK / Shattuck Labs, Inc.
|
|
|
5,664,892 |
|
|
|
2023-12-22 |
13G/A
|
US64049K2033 / Neoleukin Therapeutics, Inc.
|
|
|
1,282,661 |
|
|
|
2023-11-22 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
20,246,320 |
22,092,211 |
|
|
|
2023-11-17 |
13G
|
RGNX / REGENXBIO Inc.
|
|
1,897,223 |
4,238,312 |
|
|
|
2023-10-16 |
13G
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
4,991,545 |
|
|
|
2023-10-12 |
13G
|
IMNM / Immunome, Inc.
|
|
|
3,879,415 |
|
|
|
2023-07-27 |
13D
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
3,030,566 |
2,912,228 |
|
|
|
2023-06-28 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,033,497 |
3,291,092 |
|
|
|
2023-06-21 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
59,194,400 |
124,507,268 |
|
|
|
2023-06-15 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
20,246,320 |
20,246,320 |
|
|
|
2023-06-13 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,377,090 |
3,033,497 |
|
|
|
2023-05-04 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
20,246,320 |
20,246,320 |
|
|
|
2023-04-21 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
15,871,125 |
20,246,320 |
|
|
|
2023-04-19 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
12,993,888 |
15,071,096 |
|
|
|
2023-03-15 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
46,674,144 |
59,194,400 |
|
|
|
2023-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
9,098,725 |
9,837,493 |
|
|
|
2023-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
5,680,917 |
7,108,097 |
|
|
|
2023-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,958,284 |
4,899,772 |
|
|
|
2023-02-14 |
13G
|
AKRO / Akero Therapeutics, Inc.
|
|
1,602,285 |
2,632,912 |
|
|
|
2023-02-14 |
13G/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
2,587,730 |
2,673,837 |
|
|
|
2023-02-14 |
13G/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,088,089 |
1,608,089 |
|
|
|
2023-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
2,772,136 |
5,460,768 |
|
|
|
2023-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
5,531,000 |
5,501,389 |
|
|
|
2023-02-14 |
13G/A
|
STXS / Stereotaxis, Inc.
|
|
7,308,325 |
7,097,616 |
|
|
|
2023-02-14 |
13G/A
|
TRDA / Entrada Therapeutics, Inc.
|
|
1,954,420 |
1,854,108 |
|
|
|
2023-02-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,820,898 |
1,896,645 |
|
|
|
2023-02-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,083,501 |
3,878,599 |
|
|
|
2023-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,789,496 |
2,684,396 |
|
|
|
2023-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
6,075,918 |
6,175,918 |
|
|
|
2023-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
28,405,042 |
28,599,494 |
|
|
|
2023-02-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
4,891,693 |
4,897,575 |
|
|
|
2023-02-14 |
13G/A
|
GRTSQ / Gritstone bio, Inc.
|
|
7,265,514 |
8,483,322 |
|
|
|
2023-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
19,621,981 |
19,896,453 |
|
|
|
2023-02-14 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
4,321,560 |
3,030,566 |
|
|
|
2023-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
3,199,363 |
3,679,838 |
|
|
|
2023-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
5,165,131 |
5,740,099 |
|
|
|
2023-02-10 |
13G/A
|
ADCT / ADC Therapeutics SA
|
|
7,451,029 |
13,565,249 |
|
|
|
2023-02-08 |
13G
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
332,353 |
|
|
|
2023-02-08 |
13G/A
|
AYLA / Ayala Pharmaceuticals Inc
|
|
1,472,522 |
0 |
|
|
|
2023-02-03 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
2,246,668 |
4,166,975 |
|
|
|
2022-11-18 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
5,352,205 |
5,531,000 |
|
|
|
2022-11-18 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
4,775,461 |
5,165,131 |
|
|
|
2022-10-17 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
6,075,918 |
|
|
|
2022-10-05 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,362,460 |
3,377,090 |
|
|
|
2022-09-02 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
15,871,125 |
15,871,125 |
|
|
|
2022-08-08 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
5,758,241 |
|
|
|
2022-07-18 |
13G/A
|
ANNX / Annexon, Inc.
|
|
3,228,917 |
4,891,693 |
|
|
|
2022-07-06 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
32,556,498 |
46,674,144 |
|
|
|
2022-06-27 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
3,624,880 |
5,352,205 |
|
|
|
2022-06-15 |
13D/A
|
LSAQ / LifeSci Acquisition II Corp
|
|
19,808,234 |
19,808,234 |
|
|
|
2022-06-03 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
3,199,363 |
|
|
|
2022-05-09 |
13G
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
664,817 |
5,680,917 |
|
|
|
2022-04-06 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
11,380,031 |
32,556,498 |
|
|
|
2022-04-05 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,438,032 |
3,362,460 |
|
|
|
2022-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
2,653,902 |
2,772,136 |
|
|
|
2022-02-14 |
13G/A
|
EPZM / Epizyme Inc
|
|
10,225,405 |
3,832,475 |
|
|
|
2022-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
7,863,613 |
9,098,725 |
|
|
|
2022-02-14 |
13G/A
|
BCEL / Atreca, Inc.
|
|
2,476,068 |
800,306 |
|
|
|
2022-02-14 |
13G/A
|
ADCT / ADC Therapeutics SA
|
|
6,758,794 |
7,451,029 |
|
|
|
2022-02-14 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
2,711,616 |
2,165,586 |
|
|
|
2022-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
22,125,489 |
28,405,042 |
|
|
|
2022-02-14 |
13G/A
|
ANNX / Annexon, Inc.
|
|
3,448,030 |
3,228,917 |
|
|
|
2022-02-14 |
13G/A
|
APRE / Aprea Therapeutics, Inc.
|
|
1,268,718 |
0 |
|
|
|
2022-02-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,388,376 |
3,083,501 |
|
|
|
2022-02-14 |
13G/A
|
BEAM / Beam Therapeutics Inc.
|
|
3,778,262 |
1,885,850 |
|
|
|
2022-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
10,528,179 |
19,621,981 |
|
|
|
2022-02-14 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
4,195,658 |
4,321,560 |
|
|
|
2022-02-14 |
13G/A
|
RCEL / AVITA Medical, Inc.
|
|
1,707,386 |
672,411 |
|
|
|
2022-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,846,125 |
2,958,284 |
|
|
|
2022-02-14 |
13G/A
|
YMTX / Yumanity Therapeutics Inc
|
|
673,549 |
62,546 |
|
|
|
2022-02-14 |
13G/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
2,720,489 |
2,587,730 |
|
|
|
2022-02-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
2,123,492 |
1,897,223 |
|
|
|
2022-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,647,696 |
2,789,496 |
|
|
|
2022-02-14 |
13G/A
|
STXS / Stereotaxis, Inc.
|
|
7,833,765 |
7,308,325 |
|
|
|
2022-02-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,675,036 |
1,820,898 |
|
|
|
2022-02-14 |
13G/A
|
LVTX / LAVA Therapeutics N.V.
|
|
2,824,409 |
2,816,196 |
|
|
|
2022-02-14 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
4,437,968 |
664,817 |
|
|
|
2022-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
1,378,319 |
696,377 |
|
|
|
2022-02-14 |
13G
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
2,088,089 |
|
|
|
2022-02-14 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
5,729,916 |
7,265,514 |
|
|
|
2022-02-14 |
13G/A
|
ALLK / Allakos Inc.
|
|
2,667,451 |
2,077,875 |
|
|
|
2022-02-14 |
13G
|
TRDA / Entrada Therapeutics, Inc.
|
|
|
1,954,420 |
|
|
|
2022-02-14 |
13G/A
|
DYNS / Dynamics Special Purpose Corp Class A
|
|
2,012,900 |
0 |
|
|
|
2022-02-14 |
13G/A
|
TCRR / Tcr2 Therapeutics Inc
|
|
2,832,888 |
1,346,058 |
|
|
|
2022-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
2,686,234 |
2,246,668 |
|
|
|
2022-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
3,412,009 |
3,624,880 |
|
|
|
2022-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
4,658,043 |
4,775,461 |
|
|
|
2022-02-14 |
13G/A
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
2,416,406 |
0 |
|
|
|
2022-02-14 |
13G/A
|
AYLA / Ayala Pharmaceuticals Inc
|
|
1,381,077 |
1,472,522 |
|
|
|
2022-02-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
2,322,557 |
1,602,285 |
|
|
|
2022-01-14 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
11,380,031 |
11,380,031 |
|
|
|
2021-11-29 |
13D/A
|
MDVL / MedAvail Holdings, Inc.
|
|
12,029,652 |
11,380,031 |
|
|
|
2021-11-01 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
14,246,125 |
15,871,125 |
|
|
|
2021-10-18 |
13D
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
19,808,234 |
|
|
|
2021-09-27 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
4,915,729 |
5,729,916 |
|
|
|
2021-08-02 |
13D
|
ABSI / Absci Corporation
|
|
|
8,031,094 |
|
|
|
2021-06-07 |
13G
|
DYNS / Dynamics Special Purpose Corp Class A
|
|
|
2,012,900 |
|
|
|
2021-04-08 |
13G
|
LVTX / LAVA Therapeutics N.V.
|
|
|
2,824,409 |
|
|
|
2021-03-02 |
13G/A
|
AYLA / Ayala Pharmaceuticals Inc
|
|
667,816 |
1,381,077 |
|
|
|
2021-03-01 |
13D/A
|
AUGX / Augmedix, Inc.
|
|
|
14,246,125 |
|
|
|
2021-02-16 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
25,482,769 |
22,125,489 |
|
|
|
2021-02-16 |
13G/A
|
STXS / Stereotaxis, Inc.
|
|
7,053,462 |
7,833,765 |
|
|
|
2021-02-16 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
3,430,529 |
0 |
|
|
|
2021-02-16 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
5,494,109 |
7,863,613 |
|
|
|
2021-02-16 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
3,326,493 |
79,018 |
|
|
|
2021-02-16 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
3,621,635 |
4,658,043 |
|
|
|
2021-02-16 |
13G/A
|
TCRR / Tcr2 Therapeutics Inc
|
|
1,799,188 |
2,832,888 |
|
|
|
2021-02-16 |
13G
|
CABA / Cabaletta Bio, Inc.
|
|
|
1,378,319 |
|
|
|
2021-02-16 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
14,639,960 |
10,528,179 |
|
|
|
2021-02-16 |
13G
|
RPTX / Repare Therapeutics Inc.
|
|
|
2,647,696 |
|
|
|
2021-02-16 |
13G
|
PAYX / Paychex, Inc.
|
|
|
21,345,000 |
|
|
|
2021-02-16 |
13G
|
ADCT / ADC Therapeutics SA
|
|
|
6,758,794 |
|
|
|
2021-02-16 |
13G
|
STOK / Stoke Therapeutics, Inc.
|
|
|
2,686,234 |
|
|
|
2021-02-16 |
13G/A
|
QURE / uniQure N.V.
|
|
2,553,325 |
1,028,898 |
|
|
|
2021-02-16 |
13G/A
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
3,000,641 |
2,397,441 |
|
|
|
2021-02-16 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,090,200 |
1,675,036 |
|
|
|
2021-02-16 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
3,116,594 |
4,915,729 |
|
|
|
2021-02-16 |
13G
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
2,846,125 |
|
|
|
2021-02-16 |
13G
|
KYMR / Kymera Therapeutics, Inc.
|
|
|
2,720,489 |
|
|
|
2021-02-16 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,410,657 |
3,388,376 |
|
|
|
2021-02-16 |
13G
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
2,416,406 |
|
|
|
2021-02-16 |
13G/A
|
EPZM / Epizyme Inc
|
|
9,137,373 |
10,225,405 |
|
|
|
2021-02-16 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
1,892,521 |
2,653,902 |
|
|
|
2021-02-16 |
13G
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
4,195,658 |
|
|
|
2021-02-16 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
2,508,386 |
2,123,492 |
|
|
|
2021-02-16 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
2,940,889 |
3,412,009 |
|
|
|
2021-02-16 |
13G
|
YMTX / Yumanity Therapeutics Inc
|
|
|
673,549 |
|
|
|
2021-02-16 |
13G
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
2,711,616 |
|
|
|
2021-02-16 |
13G/A
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
4,709,498 |
4,437,968 |
|
|
|
2021-02-16 |
13G
|
US3723091043 / GenMark Diagnostics, Inc
|
|
|
4,537,400 |
|
|
|
2021-02-16 |
13G/A
|
ALLK / Allakos Inc.
|
|
3,033,526 |
2,667,451 |
|
|
|
2021-02-16 |
13G
|
ANNX / Annexon, Inc.
|
|
|
3,448,030 |
|
|
|
2021-02-16 |
13G/A
|
APRE / Aprea Therapeutics, Inc.
|
|
|
1,268,718 |
|
|
|
2021-02-16 |
13G/A
|
BCEL / Atreca, Inc.
|
|
1,136,806 |
2,476,068 |
|
|
|
2021-02-16 |
13G
|
RCEL / AVITA Medical, Inc.
|
|
|
1,707,386 |
|
|
|
2021-02-16 |
13G
|
AYLA / Ayala Pharmaceuticals Inc
|
|
|
667,816 |
|
|
|
2021-02-16 |
13G
|
BEAM / Beam Therapeutics Inc.
|
|
|
3,778,262 |
|
|
|
2021-02-16 |
13G
|
AKRO / Akero Therapeutics, Inc.
|
|
|
2,322,557 |
|
|
|
2021-01-12 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
12,661,736 |
12,993,888 |
|
|
|
2020-12-15 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,429,816 |
3,438,032 |
|
|
|
2020-11-27 |
13D
|
MDVL / MedAvail Holdings, Inc.
|
|
|
12,029,652 |
|
|
|
2020-09-10 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,144,000 |
3,429,816 |
|
|
|
2020-06-18 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
11,226,808 |
12,661,736 |
|
|
|
2020-06-09 |
13G
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
3,410,657 |
|
|
|
2020-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
9,930,003 |
25,482,769 |
|
|
|
2020-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
16,459,128 |
0 |
|
|
|
2020-02-14 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
3,564,950 |
0 |
|
|
|
2020-02-14 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,091,395 |
0 |
|
|
|
2020-02-14 |
13G/A
|
STXS / Stereotaxis, Inc.
|
|
6,961,345 |
7,053,462 |
|
|
|
2020-02-14 |
13G/A
|
VAPO / Vapotherm, Inc.
|
|
1,247,026 |
959,539 |
|
|
|
2020-02-14 |
13G/A
|
XNCR / Xencor, Inc.
|
|
3,084,703 |
0 |
|
|
|
2020-02-14 |
13G/A
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
2,412,642 |
3,000,641 |
|
|
|
2020-02-14 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
4,060,529 |
3,430,529 |
|
|
|
2020-02-14 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
2,722,388 |
|
|
|
2020-02-14 |
13G/A
|
BCEL / Atreca, Inc.
|
|
|
1,136,806 |
|
|
|
2020-02-14 |
13G
|
ALLK / Allakos Inc.
|
|
|
3,033,526 |
|
|
|
2020-02-14 |
13G/A
|
EPZM / Epizyme Inc
|
|
6,637,278 |
9,137,373 |
|
|
|
2020-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,227,507 |
0 |
|
|
|
2020-02-14 |
13G
|
QURE / uniQure N.V.
|
|
|
2,553,325 |
|
|
|
2020-02-14 |
13G
|
RGNX / REGENXBIO Inc.
|
|
|
2,508,386 |
|
|
|
2020-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
4,414,617 |
5,494,109 |
|
|
|
2020-02-14 |
13G/A
|
BOLD / Boundless Bio, Inc.
|
|
2,301,667 |
639,095 |
|
|
|
2020-02-14 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
2,237,607 |
3,326,493 |
|
|
|
2020-02-14 |
13G
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
4,709,498 |
|
|
|
2020-02-14 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
2,269,135 |
3,116,594 |
|
|
|
2020-02-14 |
13G
|
FTSV / Forty Seven, Inc.
|
|
|
2,770,842 |
|
|
|
2020-02-14 |
13G/A
|
IFRX / InflaRx N.V.
|
|
2,035,400 |
0 |
|
|
|
2020-02-14 |
13G
|
KRYS / Krystal Biotech, Inc.
|
|
|
1,090,200 |
|
|
|
2020-02-14 |
13G/A
|
NITE / Capitol Series Trust - The Nightview Fund
|
|
1,795,846 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
1,761,407 |
2,940,889 |
|
|
|
2020-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
2,188,956 |
3,621,635 |
|
|
|
2020-02-14 |
13G/A
|
TCRR / Tcr2 Therapeutics Inc
|
|
1,807,256 |
1,799,188 |
|
|
|
2020-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
1,892,179 |
1,892,521 |
|
|
|
2020-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
10,884,607 |
14,639,960 |
|
|
|
2019-10-24 |
13D/A
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
8,367,616 |
25,000 |
|
|
|
2019-09-24 |
13D
|
IGMS / IGM Biosciences, Inc.
|
|
|
3,144,000 |
|
|
|
2019-09-17 |
13D/A
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
8,313,506 |
8,367,616 |
|
|
|
2019-09-17 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
10,359,666 |
11,226,808 |
|
|
|
2019-08-12 |
13G
|
STXS / Stereotaxis, Inc.
|
|
|
6,961,345 |
|
|
|
2019-06-25 |
13G
|
BCEL / Atreca, Inc.
|
|
1,140,306 |
1,140,306 |
|
|
|
2019-06-24 |
13G
|
BCEL / Atreca, Inc.
|
|
|
1,140,306 |
|
|
|
2019-04-24 |
13G
|
HOOK / HOOKIPA Pharma Inc.
|
|
|
1,892,179 |
|
|
|
2019-03-06 |
13D/A
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
6,807,876 |
8,313,506 |
|
|
|
2019-02-21 |
13G
|
TCRR / Tcr2 Therapeutics Inc
|
|
|
1,807,256 |
|
|
|
2019-02-14 |
13G
|
CLVS / Clovis Oncology Inc
|
|
|
4,060,529 |
|
|
|
2019-02-14 |
13G
|
IFRX / InflaRx N.V.
|
|
|
2,035,400 |
|
|
|
2019-02-14 |
13G
|
EPZM / Epizyme Inc
|
|
|
6,637,278 |
|
|
|
2019-02-14 |
13G
|
SRRK / Scholar Rock Holding Corporation
|
|
|
1,761,407 |
|
|
|
2019-02-14 |
13G
|
BOLD / Boundless Bio, Inc.
|
|
|
2,301,667 |
|
|
|
2019-02-14 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
2,209,107 |
2,237,607 |
|
|
|
2019-02-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
2,179,655 |
2,188,956 |
|
|
|
2019-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
2,815,988 |
4,414,617 |
|
|
|
2019-02-14 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
2,242,629 |
2,269,135 |
|
|
|
2019-02-14 |
13G/A
|
NITE / Capitol Series Trust - The Nightview Fund
|
|
1,772,843 |
1,795,846 |
|
|
|
2019-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
2,318,387 |
2,227,507 |
|
|
|
2019-02-14 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
2,594,339 |
707,547 |
|
|
|
2019-02-14 |
13G/A
|
EHTH / eHealth, Inc.
|
|
1,558,914 |
1,091,395 |
|
|
|
2019-02-14 |
13G
|
XNCR / Xencor, Inc.
|
|
|
3,084,703 |
|
|
|
2019-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
1,930,668 |
1,978,547 |
|
|
|
2019-02-14 |
13G/A
|
VAPO / Vapotherm, Inc.
|
|
1,259,540 |
1,247,026 |
|
|
|
2019-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
12,085,770 |
9,930,003 |
|
|
|
2019-02-14 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
2,096,490 |
0 |
|
|
|
2019-02-14 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
3,832,778 |
3,564,950 |
|
|
|
2019-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
19,113,864 |
16,459,128 |
|
|
|
2019-02-14 |
13G/A
|
US29266S3040 / Endologix, Inc.
|
|
5,928,101 |
800,476 |
|
|
|
2019-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
10,906,962 |
10,884,607 |
|
|
|
2018-11-16 |
13G
|
VAPO / Vapotherm, Inc.
|
|
|
1,259,540 |
|
|
|
2018-10-03 |
13G
|
GRTS / Gritstone bio, Inc.
|
|
|
2,242,629 |
|
|
|
2018-09-27 |
13D/A
|
FATE / Fate Therapeutics, Inc.
|
|
6,655,962 |
10,359,666 |
|
|
|
2018-08-02 |
13D
|
FATE / Fate Therapeutics, Inc.
|
|
66,559,623 |
6,655,962 |
|
|
|
2018-07-27 |
13G
|
NITE / Capitol Series Trust - The Nightview Fund
|
|
|
1,772,843 |
|
|
|
2018-07-25 |
13G
|
REPL / Replimune Group, Inc.
|
|
|
2,179,655 |
|
|
|
2018-06-27 |
13G
|
XERS / Xeris Biopharma Holdings, Inc.
|
|
|
2,412,642 |
|
|
|
2018-04-26 |
13D/A
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
6,807,876 |
6,807,876 |
|
|
|
2018-03-23 |
13D
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
6,505,766 |
6,807,876 |
|
|
|
2018-03-08 |
13G
|
LIFE / aTyr Pharma, Inc.
|
|
|
2,594,339 |
|
|
|
2018-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
2,670,942 |
2,815,988 |
|
|
|
2018-02-14 |
13G/A
|
US29266S3040 / Endologix, Inc.
|
|
|
5,928,101 |
|
|
|
2018-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
|
10,906,962 |
|
|
|
2018-02-14 |
13G/A
|
LUMO / Lumos Pharma, Inc.
|
|
|
2,096,490 |
|
|
|
2018-02-14 |
13G/A
|
CMRX / Chimerix, Inc.
|
|
3,345,959 |
3,832,778 |
|
|
|
2018-02-14 |
13G/A
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
6,505,766 |
|
|
|
2018-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
14,391,130 |
12,085,770 |
|
|
|
2018-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
16,618,776 |
19,113,864 |
|
|
|
2018-02-14 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
|
1,930,668 |
|
|
|
2018-02-14 |
13G/A
|
NDRM / NeuroDerm Ltd.
|
|
1,560,819 |
0 |
|
|
|
2018-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
1,701,049 |
2,318,387 |
|
|
|
2018-02-14 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
66,559,625 |
6,655,962 |
|
|
|
2018-02-14 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
1,578,174 |
1,558,392 |
|
|
|
2018-02-14 |
13G/A
|
EHTH / eHealth, Inc.
|
|
997,621 |
1,558,914 |
|
|
|
2018-02-14 |
13G
|
WVE / Wave Life Sciences Ltd.
|
|
|
2,209,107 |
|
|
|
2017-12-19 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
4,593,392 |
6,655,962 |
|
|
|
2017-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
11,630,618 |
14,391,130 |
|
|
|
2017-02-14 |
13G/A
|
NDRM / NeuroDerm Ltd.
|
|
1,589,261 |
1,560,819 |
|
|
|
2017-02-14 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
|
1,701,049 |
|
|
|
2017-02-14 |
13G
|
PRQR / ProQR Therapeutics N.V.
|
|
|
1,578,174 |
|
|
|
2017-02-14 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
3,790,024 |
4,593,392 |
|
|
|
2017-02-14 |
13G/A
|
/ Array BioPharma, Inc.
|
|
18,418,106 |
16,618,776 |
|
|
|
2017-02-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
1,534,962 |
2,670,942 |
|
|
|
2017-02-14 |
13G
|
CMRX / Chimerix, Inc.
|
|
|
3,345,959 |
|
|
|
2017-02-14 |
13G
|
EHTH / eHealth, Inc.
|
|
|
997,621 |
|
|
|
2016-12-05 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
2,371,001 |
3,790,024 |
|
|
|
2016-02-16 |
13G/A
|
TRIV / TriVascular Technologies, Inc.
|
|
|
1,462,762 |
|
|
|
2016-02-16 |
13G
|
FATE / Fate Therapeutics, Inc.
|
|
|
2,371,001 |
|
|
|
2016-02-16 |
13G
|
NDRM / NeuroDerm Ltd.
|
|
|
1,589,261 |
|
|
|
2016-02-16 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
2,863,003 |
|
|
|
2016-02-16 |
13G
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
1,534,962 |
|
|
|
2016-02-16 |
13G
|
NSTG / NanoString Technologies, Inc.
|
|
|
1,357,692 |
|
|
|
2016-02-16 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
11,630,618 |
|
|
|
2016-02-16 |
13G/A
|
MODN / Model N, Inc.
|
|
|
1,868,159 |
|
|
|
2016-02-16 |
13G/A
|
/ Array BioPharma, Inc.
|
|
15,396,573 |
18,418,106 |
|
|
|
2015-09-10 |
13G/A
|
/ Array BioPharma, Inc.
|
|
|
15,396,573 |
|
|
|
2015-02-24 |
13G/A
|
TRIV / TriVascular Technologies, Inc.
|
|
|
1,755,568 |
|
|
|
2015-02-18 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
8,475,274 |
|
|
|
2015-02-18 |
13G
|
MODN / Model N, Inc.
|
|
|
1,461,678 |
|
|
|
2015-02-18 |
13G
|
NSTG / NanoString Technologies, Inc.
|
|
|
1,266,538 |
|
|
|
2015-02-18 |
13G/A
|
/ Oxford Immunotec Global PLC
|
|
|
1,070,995 |
|
|
|
2015-02-18 |
13G
|
/ Array BioPharma, Inc.
|
|
|
12,142,022 |
|
|
|
2015-02-18 |
13G
|
/ Oxford Immunotec Global PLC
|
|
|
1,070,995 |
|
|
|
2014-10-09 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
7,356,906 |
|
|
|
2013-11-29 |
13G
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
8,648,087 |
|
|
|
2013-10-03 |
13G/A
|
CYCC / Cyclacel Pharmaceuticals, Inc.
|
|
|
0 |
|
|
|
2013-02-14 |
13G
|
CYCC / Cyclacel Pharmaceuticals, Inc.
|
|
|
672,680 |
|
|
|
2012-04-06 |
13G
|
CYCC / Cyclacel Pharmaceuticals, Inc.
|
|
|
5,329,095 |
|
|
|